In pancreatic cancer, PRMT3 enhances chemoresistance by methylating heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1), which stabilizes ABCG2 mRNA [24]. This evidence concerns the gene PRMT3 and pancreatic neoplasm.